NCT00123825View on ClinicalTrials.gov

Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Gallbladder CancerBiliary Tract Cancer
Interventions
DRUG

Gemcitabine

DRUG

Cisplatin

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Eli Lilly and Company

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER

NCT00123825 - Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | Biotech Hunter | Biotech Hunter